TG Therapeutics Inc (TGTX)
17.16
+0.65
(+3.94%)
USD |
NASDAQ |
May 07, 16:00
17.16
0.00 (0.00%)
After-Hours: 16:24
TG Therapeutics Gross Profit Margin (Quarterly): 91.43% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 91.43% |
December 31, 2023 | 82.14% |
September 30, 2023 | 97.88% |
June 30, 2023 | 88.11% |
March 31, 2023 | 89.02% |
December 31, 2022 | 96.25% |
September 30, 2022 | 97.87% |
June 30, 2022 | 96.13% |
March 31, 2022 | 88.24% |
December 31, 2021 | 90.95% |
September 30, 2021 | 85.62% |
June 30, 2021 | 90.42% |
March 31, 2021 | 82.47% |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 |
Date | Value |
---|---|
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
82.14%
Minimum
Dec 2023
97.88%
Maximum
Sep 2023
90.50%
Average
90.42%
Median
Jun 2021
Gross Profit Margin (Quarterly) Benchmarks
Amicus Therapeutics Inc | 90.16% |
Geron Corp | -- |
Editas Medicine Inc | -- |
G1 Therapeutics Inc | 92.55% |
Mersana Therapeutics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | 37.23% |
Return on Assets | 14.18% |
Return on Invested Capital | 9.31% |
Profit Margin (Quarterly) | -16.87% |
Operating Margin (Quarterly) | -14.60% |
Return on Net Operating Assets | 54.73% |